ASWINI S, BABU EZHUMALAI, HANUSHA V, and SETHUMEENA S, “A STUDY ON THE PREVALENCE OF ADVERSE EFFECTS ASSOCIATED WITH SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR DAPAGLIFLOZIN IN A TERTIARY CARE CENTRE”, Asian J Pharm Clin Res, vol. 17, no. 12, pp. 147–150, Dec. 2024.